Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Inc. Aventis currently holds 3,724,002 shares of INTROGEN THERAPEUTICS INC (INGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Inc. Aventis has been a net seller of INGN stock. They have purchased $0 and sold $1.3M worth of shares.
Inc. Aventis's most recent insider trade was on Sep 6, 2006, when they sold 20,439 shares at $4.04 per share.
Inc. Aventis serves as Executive at INTROGEN THERAPEUTICS INC (INGN). They have executed 11 insider transactions totaling $1.3M over their tenure at the company.
Inc. Aventis holds the position of Executive at INTROGEN THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Inc. Aventis has shown a selling trading pattern, with $0 in total purchases and $1.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Inc. Aventis was on Apr 4, 2006, when they sold $356.9K worth of INGN shares. This transaction involved 65,845 shares at $5.42 per share.
Inc. Aventis currently owns 3,724,002 shares of INTROGEN THERAPEUTICS INC (INGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Inc. Aventis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Inc. Aventis has 11 Form 4 filings on record as an insider at INTROGEN THERAPEUTICS INC.
Set alerts for Inc. Aventis and 40,000+ other insiders.